CAS No.87239-81-4,Cefpodoxime proxetil Suppliers

Products Categories

Pharmaceutical (105)
Others (32)
Organic Chemicals (21)
Reagent (2)
Materials (2)

Basic Information

Molecular Structure:
CAS No.:	87239-81-4
Name:	Cefpodoxime proxetil
Article Data:	10

Formula:	C₂₁H₂₇N₅O₉S₂
Molecular Weight:	557.605
Synonyms:	5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-,1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester, [6R-[6a,7b(Z)]]-;5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2Z)-(2-amino-4-thiazolyl)(methoxyimino)acetyl]amino]-3-(methoxymethyl)-8-oxo-,1-[[(1-methylethoxy)carbonyl]oxy]ethyl ester, (6R,7R)- (9CI);(RS)-1-(Isopropoxycarbonyloxy)ethyl (+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-[(Z)-(methoxyimino]acetamido]-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate;Antibiotic CS 807;Banan;CS 807;CS 807 (pharmaceutical);Cefodox;Cefoprox;Cepodem;Orelox;Otreon;RU 51807;U 76252;Vantin;Cefpodoxime proxetil;
EINECS:	1308068-626-2
Density:	1.58 g/cm³
Melting Point:	111-113 °C
Appearance:	pale yellow solid
Hazard Symbols:	Xi
Risk Codes:	36/37/38-42/43
Safety:	22-26-36/37/39
PSA:	234.51000
LogP:	1.73700

Raw Materials

957-68-6

Total:136 Page 1 of 4 1 2 3 4 Next>>

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 87239-81-4

Specification

The Cefpodoxime proxetil, with the CAS registry number 87239-81-4,is also known as Vantin; (RS)-1(Isopropoxycarbonyloxy)ethyl (+)-(6R,7R)-7-[2-(2-amino-4-thiazolyl)-2-[(Z)methoxyimino]acetamido]-3-methoxymethyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate. It belongs to the product categories of Isotope Labeled Compounds;Metabolites & Impurities;Cefpodoxime. This chemical's molecular formula is C21H27N5O9S2 and molecular weight is 557.59. What's more,Its systematic name is Cefpodoxime proxetil.It is a Pale Yellow Solid which is an antibacterial. A broad spectrum, orally absorbed third generation cephalosporin, ester prodrug of the active free acid metabolite, Cefpodoxime

Physical properties about Cefpodoxime proxetil are:
(1)ACD/LogP: 2.946; (2)# of Rule of 5 Violations: 2; (3)ACD/LogD (pH 5.5): 2.95; (4)ACD/LogD (pH 7.4): 2.86; (5)ACD/BCF (pH 5.5): 101.75; (6)ACD/BCF (pH 7.4): 84.38; (7)ACD/KOC (pH 5.5): 951.20; (8)ACD/KOC (pH 7.4): 788.76; (9)#H bond acceptors: 14; (10)#H bond donors: 3; (11)#Freely Rotating Bonds: 13; (12)Index of Refraction: 1.671; (13)Molar Refractivity: 131.765 cm3; (14)Molar Volume: 352.527 cm3; (15)Polarizability: 52.236 10-24cm3 ; (16)Surface Tension: 60.0359992980957 dyne/cm; (17)Density: 1.582 g/cm3.

You can still convert the following datas into molecular structure:
(1)SMILES:O=C2N1/C(=C(\CS[C@@H]1[C@@H]2NC(=O)C(=N\OC)/c3nc(sc3)N)COC)C(=O)OC(OC(=O)OC(C)C)C;
(2)Std. InChI:InChI=1S/C21H27N5O9S2/c1-9(2)33-21(30)35-10(3)34-19(29)15-11(6-31-4)7-36-18-14(17(28)26(15)18)24-16(27)13(25-32-5)12-8-37-20(22)23-12/h8-10,14,18H,6-7H2,1-5H3,(H2,22,23)(H,24,27)/b25-13-/t10?,14-,18-/m1/s1;
(3)Std. InChIKey:LTINZAODLRIQIX-FBXRGJNPSA-N.

Safety Information of Cefpodoxime proxetil :
The Cefpodoxime proxetil is irritating to eyes, respiratory system and skin. And it may cause sensitization by inhalation and skin contact. When you use it ,please do not breathe dust and wear suitable protective clothing, gloves and eye/face protection.In case of contact with eyes, rinse immediately with plenty of water and seek medical advice.

The toxicity data of Cefpodoxime proxetil are as follows:

Organism	Test Type	Route	Reported Dose (Normalized Dose)	Effect	Source
dog	LD50	oral	> 800mg/kg (800mg/kg)		Chemotherapy Vol. 36(Suppl,
mouse	LD50	intraperitoneal	2535mg/kg (2535mg/kg)	BLOOD: CHANGES IN SPLEEN LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Chemotherapy Vol. 36(Suppl,
mouse	LD50	oral	> 8gm/kg (8000mg/kg)		Chemotherapy Vol. 36(Suppl,
mouse	LD50	subcutaneous	> 10gm/kg (10000mg/kg)	SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Chemotherapy Vol. 36(Suppl,
rat	LD50	intraperitoneal	> 4gm/kg (4000mg/kg)	BLOOD: CHANGES IN SPLEEN LUNGS, THORAX, OR RESPIRATION: DYSPNEA BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)	Chemotherapy Vol. 36(Suppl,
rat	LD50	oral	> 4gm/kg (4000mg/kg)		Chemotherapy Vol. 36(Suppl,
rat	LD50	subcutaneous	> 2gm/kg (2000mg/kg)	BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY) SKIN AND APPENDAGES (SKIN): "DERMATITIS, OTHER: AFTER SYSTEMIC EXPOSURE" LUNGS, THORAX, OR RESPIRATION: DYSPNEA	Chemotherapy Vol. 36(Suppl,